SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 455 filers reported holding SAREPTA THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 1.01 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,861,000 | +5.5% | 31,949 | -0.1% | 0.01% | 0.0% |
| Q2 2023 | $3,658,000 | -29.4% | 31,980 | -14.8% | 0.01% | -36.4% |
| Q1 2023 | $5,182,000 | +4.9% | 37,537 | -1.7% | 0.01% | 0.0% |
| Q4 2022 | $4,940,000 | +16.2% | 38,169 | -0.7% | 0.01% | 0.0% |
| Q3 2022 | $4,252,000 | +10.8% | 38,432 | -33.6% | 0.01% | +10.0% |
| Q2 2022 | $3,837,000 | +25.6% | 57,865 | +48.4% | 0.01% | +42.9% |
| Q1 2022 | $3,056,000 | -13.4% | 38,985 | -0.2% | 0.01% | -12.5% |
| Q4 2021 | $3,529,000 | -5.4% | 39,063 | -3.4% | 0.01% | -20.0% |
| Q3 2021 | $3,731,000 | +18.6% | 40,427 | +0.1% | 0.01% | +11.1% |
| Q2 2021 | $3,147,000 | +25.0% | 40,386 | +19.5% | 0.01% | +12.5% |
| Q1 2021 | $2,518,000 | -53.2% | 33,809 | +7.2% | 0.01% | -63.6% |
| Q4 2020 | $5,382,000 | +35.5% | 31,539 | +10.8% | 0.02% | +15.8% |
| Q3 2020 | $3,971,000 | -14.0% | 28,468 | -1.9% | 0.02% | -24.0% |
| Q2 2020 | $4,616,000 | +56.9% | 29,030 | -4.3% | 0.02% | +31.6% |
| Q1 2020 | $2,942,000 | -24.9% | 30,323 | -1.9% | 0.02% | -17.4% |
| Q4 2019 | $3,920,000 | +61.8% | 30,906 | -6.6% | 0.02% | +76.9% |
| Q3 2019 | $2,423,000 | -54.4% | 33,078 | -5.9% | 0.01% | -59.4% |
| Q2 2019 | $5,319,000 | +9.8% | 35,134 | -13.9% | 0.03% | 0.0% |
| Q1 2019 | $4,845,000 | +0.2% | 40,793 | -7.9% | 0.03% | -13.5% |
| Q4 2018 | $4,833,000 | -38.3% | 44,314 | -8.7% | 0.04% | -33.9% |
| Q3 2018 | $7,830,000 | +20.6% | 48,524 | -1.3% | 0.06% | +9.8% |
| Q2 2018 | $6,491,000 | +48.6% | 49,176 | -16.6% | 0.05% | +37.8% |
| Q1 2018 | $4,368,000 | +14.2% | 58,960 | -13.9% | 0.04% | +19.4% |
| Q4 2017 | $3,824,000 | +20.7% | 68,518 | -1.8% | 0.03% | +14.8% |
| Q3 2017 | $3,168,000 | +76.0% | 69,796 | +30.5% | 0.03% | +68.8% |
| Q2 2017 | $1,800,000 | +30.2% | 53,477 | +13.6% | 0.02% | +23.1% |
| Q1 2017 | $1,382,000 | +21.9% | 47,075 | +13.8% | 0.01% | +8.3% |
| Q4 2016 | $1,134,000 | -40.0% | 41,350 | +34.2% | 0.01% | -45.5% |
| Q3 2016 | $1,891,000 | +153.1% | 30,810 | -20.9% | 0.02% | +144.4% |
| Q2 2016 | $747,000 | +116.5% | 38,957 | +120.7% | 0.01% | +800.0% |
| Q1 2016 | $345,000 | – | 17,654 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Casdin Capital, LLC | 1,315,000 | $170,397,700 | 13.20% |
| EcoR1 Capital, LLC | 2,999,453 | $388,669,120 | 11.83% |
| Evolutionary Tree Capital Management, LLC | 63,756 | $8,261,502 | 7.93% |
| Tri Locum Partners LP | 119,695 | $15,510,000 | 6.27% |
| Avoro Capital Advisors LLC | 3,175,000 | $411,416,500 | 6.15% |
| Camber Capital Management LP | 1,250,000 | $161,975 | 5.56% |
| Finepoint Capital LP | 131,457 | $17,034 | 5.51% |
| ACUTA CAPITAL PARTNERS, LLC | 67,500 | $8,746,650 | 5.38% |
| Logos Global Management LP | 220,000 | $28,507,600 | 3.34% |
| AFG FIDUCIARY SERVICES LIMITED PARTNERSHIP | 33,454 | $3,401,657 | 3.20% |